About Aprecap 80 Tablet
Aprecap 80 Tablet, a laureate in antiemetic therapy, stands as a preeminent solution for adults facing chemotherapy-induced nausea and vomiting (CINV). Marketed by Glenmark Pharmaceuticals Ltd., this allopathic marvel contains Aprepitant 80 mg-an NK1 receptor antagonist endorsed by USFDA and India CDSCO. Supplied in vivid pink, oval tablets, Aprecap 80 ensures effective relief when taken as directed by your physician. Limited stock available at a special rate-get optimal protection as part of combination therapy. Prescription only. Store securely below 30C.
Therapeutic Applications and Competitive Advantages
Aprecap 80 Tablet is used exclusively as part of combination therapy for the prevention of nausea and vomiting associated with cancer chemotherapy. Its preeminent efficacy stems from its NK1 receptor antagonist action, offering superlative control over CINV compared to standard antiemetic regimens. While primarily indicated for chemo-induced nausea, its competitive advantage lies in reliable performance and regulatory approval, contributing to improved quality of life for adults undergoing cancer treatment. Available only by prescription, ensuring patient safety.
Sample Availability, Export Market, and Supply Estimation
Aprecap 80 Tablet samples are available for qualified healthcare suppliers and traders. We hand over products promptly, ensuring secure blister-pack shipping under optimal conditions. Main export markets include India and several international sectors, facilitated by Glenmark's robust distribution network. With our steady supply ability, shipments are estimated to reach clients swiftly, maintaining product efficacy. For an accurate estimate of order delivery timelines or to request a sample, simply contact our distributor or trading partner.
FAQ's of Aprecap 80 Tablet:
Q: How should Aprecap 80 Tablet be taken for optimal benefit?
A: Take one Aprecap 80 Tablet orally, exactly as prescribed by your physician, usually in combination with other antiemetics, before starting chemotherapy. Follow the dosage guidelines closely to optimize its preventive effect against nausea and vomiting.
Q: What sets Aprecap 80 Tablet apart from other antiemetics?
A: Aprecap 80 Tablet stands out for its superlative effectiveness in controlling chemotherapy-induced nausea and vomiting due to its unique action as an NK1 receptor antagonist and prestigious international regulatory approvals.
Q: When is Aprecap 80 Tablet indicated for use?
A: This medication is indicated only for adults undergoing chemotherapy, specifically to prevent acute and delayed nausea and vomiting as a part of a combination regimen.
Q: Where should Aprecap 80 Tablet be stored to maintain efficacy?
A: Store the tablets below 30C, protected from light and moisture, in their original blister packaging to preserve their quality and efficacy throughout their 24-month shelf life.
Q: What are the potential side effects of using Aprecap 80 Tablet?
A: Common side effects may include fatigue, constipation, hiccups, and loss of appetite. Consult your healthcare provider if you experience any hypersensitivity or persistent symptoms.
Q: How is Aprecap 80 Tablet supplied and packaged?
A: Each box contains one strip of four pink, oval oral tablets packed in a blister pack, with a shelf life of 24 months from the date of manufacture.